Abstract #0986
Reduction of (1- 13 C)-dehydroascorbic acid to (1- 13 C)-ascorbic acid is not correlated to glutathione in a treatment response model of murine lymphoma in vivo
Kerstin N Timm 1,2 , Mikko I Kettunen 1,2 , De E Hu 1,2 , Tiago B Rodrigues 1,2 , Timothy J Larkin 1,2 , Irene Marco-Rius 1,2 , and Kevin M Brindle 1,2
1
Department of Biochemistry, University of
Cambridge, Cambridge, Cambridgshire, United Kingdom,
2
Cancer
Research UK Cambridge Institute, University of
Cambridge, Cambridge, Cambridgshire, United Kingdom
Hyperpolarized [1-13C]-dehydroascorbic acid (DHA), the
oxidized form of vitamin C, can be used as a magnetic
resonance marker of redox state in vitro and in vivo.
What limits the reduction of hyperpolarized [1-13C]-DHA
to [1-13C]-ascorbic acid (AA) in vivo and hence which
metabolic process it directly reports on is still poorly
understood. We treated EL4 tumor bearing mice with the
topoisomerase inhibitor etoposide and showed that the
reduction rate of hyperpolarized [1-13C]-DHA in vivo is
highly variable, which was not correlated with
intracellular glutathione levels. This suggests
contribution of other factors such as NADPH from the
pentose phosphate pathway.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Click here for more information on becoming a member.
